RECRUITING

Healing At Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.

Official Title

Healing At Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression

Quick Facts

Study Start:2025-03-13
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06877104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Postpartum patients who have delivered a singleton baby at or after 37w0d at the Hospital of the University of Pennsylvania
  2. * Self-identify as a person of color (listed on chart as non-White race and confirmed with patient)
  3. * Able to speak, read and write English
  4. * Age ≥18
  5. * Prenatal care at outpatient practice affiliated with the Hospital of the University of Pennsylvania
  6. * Completion of clinically administered EPDS during inpatient stay
  7. * Routine discharge timing, day 2 or more after vaginal delivery, day 3 or more after cesarean delivery
  1. * Unable to provide informed consent
  2. * Baby not discharged with mother at postpartum discharge
  3. * Does not have access to a mobile phone

Contacts and Locations

Study Contact

Meaghan G McCabe, MPH
CONTACT
973-747-2824
meaghan.mccabe@pennmedicine.upenn.edu
Angelina Malenda
CONTACT
551-482-3655
angelina.malenda@pennmedicine.upenn.edu

Principal Investigator

Kirstin Leitner, MD
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: University of Pennsylvania

  • Kirstin Leitner, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-13
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2025-03-13
Study Completion Date2026-06-30

Terms related to this study

Keywords Provided by Researchers

  • Chat tool
  • Depression
  • Text message based program
  • Postpartum Care

Additional Relevant MeSH Terms

  • Depression, Postpartum
  • Postpartum Care